Sugi Predict

Sugi Predict / Compounds / SCHEMBL7748673

SCHEMBL7748673

SCHEMBL7748673

N=C(N)N/N=C/c1cccc(Cl)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIN2D O15399 2/20 0.55
▸ GRIN3B O60391 2/20 0.55
▸ GRIN1 Q05586 2/20 0.55
▸ GRIN2A Q12879 2/20 0.55
▸ GRIN2B Q13224 2/20 0.55
▸ GRIN2C Q14957 2/20 0.55
▸ GRIN3A Q8TCU5 2/20 0.55
▸ POLB P06746 3/20 0.54
▸ CHRM5 P08912 1/20 0.53
▸ NPC1 O15118 2/20 0.52
▸ RAB9A P51151 2/20 0.52
▸ LMNA P02545 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ NPSR1 Q6W5P4 1/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ GUSB P08236 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ MAOB P27338 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7748676 1.00 GRIN2D (0.55) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Hydrochloric Acid SCHEMBL5703049 0.98 GRIN2D (0.56) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Hydrochloric Acid SCHEMBL5703045 0.98 GRIN2D (0.56) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Acetic Acid SCHEMBL21519499 0.92 NPC1 (0.55) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6742928 0.88 POLB (0.68) POLBLMNAKMT2AMAOBKDM4E
SCHEMBL20148189 0.88 POLB (0.68) POLBLMNAKMT2AMAOBKDM4E
SCHEMBL6742923 0.88 POLB (0.68) POLBLMNAKMT2AMAOBKDM4E
SCHEMBL16224344 0.87 CHRM5 (0.56) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Hydrochloric Acid SCHEMBL17560969 0.85 CHRM5 (0.55) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL24278570 0.84 POLB (0.78) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180111896-A1 INHIBITORS AND THEIR USES MEDICAL RESEARCH COUNCIL (GB) 2018-04-26 — — US claimed
CN-107709291-A Inhibitors and uses thereof 医疗研究局 2018-02-16 — — CN claimed
EP-3280405-A1 INHIBITORS AND THEIR USES Medical Research Council (GB) 2018-02-14 — — EP claimed
WO-2016162689-A1 INHIBITORS AND THEIR USES MEDICAL RESEARCH COUNCIL (GB) 2016-10-13 — — WO claimed
WO-2001025192-A1 GUANIDINE DERIVATIVES AND THEIR USE IN THE PRODUCTION OF A MEDICAMENT FOR BLOCKING XANTHINE OXIDASE/DEHYDROGENASE MELACURE THERAPEUTICS AB (SE) 2001-04-12 — — WO claimed
US-11566012-B2 Methods for treating protozoan infections NEOCULI PTY LTD (AU) 2023-01-31 — — US disclosed
US-11337941-B2 Inhibitors and their uses UNITED KINGDOM RESEARCH AND INNOVATION (GB) 2022-05-24 — — US disclosed
US-11337941-B2 Inhibitors and their uses UNITED KINGDOM RESEARCH AND INNOVATION (GB) 2022-05-24 — — US disclosed
US-11331286-B2 Inhibitors and their uses UNITED KINGDOM RESEARCH AND INNOVATION (GB) 2022-05-17 — — US disclosed
US-11331286-B2 Inhibitors and their uses UNITED KINGDOM RESEARCH AND INNOVATION (GB) 2022-05-17 — — US disclosed
EP-3960729-A1 COMPOUNDS AND METHODS OF TREATING INFECTIONS Neoculi Pty Ltd (AU) 2022-03-02 — — EP disclosed
EP-2991968-B1 COMPOUNDS AND METHODS OF TREATING INFECTIONS NEOCULI PTY LTD (AU) 2021-11-10 — — EP disclosed
EP-3280405-A1 INHIBITORS AND THEIR USES Medical Research Council (GB) 2018-02-14 — — EP disclosed
US-20170291886-A1 METHODS FOR TREATING PROTOZOAN INFECTIONS NEOCULI PTY LTD (AU) 2017-10-12 — — US disclosed
WO-2016162689-A1 INHIBITORS AND THEIR USES MEDICAL RESEARCH COUNCIL (GB) 2016-10-13 — — WO disclosed
WO-2016162689-A1 INHIBITORS AND THEIR USES MEDICAL RESEARCH COUNCIL (GB) 2016-10-13 — — WO disclosed
WO-2016033635-A1 METHODS FOR TREATING PROTOZOAN INFECTIONS NEOCULI PTY LTD (AU) 2016-03-10 — — WO disclosed
US-20150246140-A1 COMPOSITIONS AND METHODS FOR MODULATING SLEEP AND WAKEFULNESS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2015-09-03 — — US disclosed
WO-2014176636-A1 COMPOUNDS AND METHODS OF TREATING INFECTIONS NEOCULI PTY LTD (AU) 2014-11-06 — — WO disclosed
WO-2001025192-A1 GUANIDINE DERIVATIVES AND THEIR USE IN THE PRODUCTION OF A MEDICAMENT FOR BLOCKING XANTHINE OXIDASE/DEHYDROGENASE MELACURE THERAPEUTICS AB (SE) 2001-04-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11566012-B2 Methods for treating protozoan infections DPM1, ABCB11, PIGS GRIN2D 4499/4885GRIN3B 4132/4885GRIN1 3786/4885
US-20180111896-A1 INHIBITORS AND THEIR USES PPP1R1B, PPP5C, PPP1R15A GRIN2D 4749/4885GRIN3B 4192/4885GRIN1 2772/4885
US-20170291886-A1 METHODS FOR TREATING PROTOZOAN INFECTIONS DPM1, ABCB11, PIGS GRIN2D 4499/4885GRIN3B 4132/4885GRIN1 3786/4885
US-11331286-B2 Inhibitors and their uses PPP1R1B, PPP5C, PPP1R15A GRIN2D 4749/4885GRIN3B 4192/4885GRIN1 2772/4885
US-20150246140-A1 COMPOSITIONS AND METHODS FOR MODULATING SLEEP AND WAKEFULNESS HCRTR2, HCRTR1, NPSR1 GRIN2D 791/4885GRIN3B 229/4885GRIN1 301/4885
US-11337941-B2 Inhibitors and their uses PPP1R1B, PPP5C, PPP1R15A GRIN2D 4749/4885GRIN3B 4192/4885GRIN1 2772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.